BD (Becton, Dickinson and Company), a leading global medical technology company, has announced a strategic partnership with Wellstar Health System,…
Read More
Insilico Medicine and Eli Lilly Forge Potentially $2.75 Billion AI-Driven Drug Discovery Alliance, Signaling a New Era of Pharmaceutical Innovation
On March 29, Insilico Medicine, a pioneering company in artificial intelligence-driven drug discovery and development, announced a landmark collaboration with…
Read More
OpenBench and Concept Life Sciences Forge Strategic Alliance to Revolutionize Early-Stage Drug Discovery with Fee-for-Success Model
A groundbreaking strategic partnership has been announced between OpenBench, a pioneer in AI-driven drug discovery, and Concept Life Sciences, a…
Read More
Labcorp and Children’s Hospital of Philadelphia Forge Alliance to Revolutionize Pediatric Diagnostics and Expand National Access
The landscape of clinical diagnostics is poised for a significant transformation following the announcement of a strategic collaboration between Labcorp,…
Read More
Labcorp and Children’s Hospital of Philadelphia Forge Strategic Alliance to Revolutionize Pediatric Diagnostics and National Access
Labcorp, a leading global life sciences company, and the Children’s Hospital of Philadelphia (CHOP), a globally recognized leader in pediatric…
Read More
Labcorp and Children’s Hospital of Philadelphia Forge Strategic Alliance to Advance Pediatric Diagnostics and National Access
Labcorp, a leading global life sciences company, and the Children’s Hospital of Philadelphia (CHOP), a preeminent pediatric research and clinical…
Read More
OZMOSI and Planview Forge Strategic Alliance to Revolutionize Pharmaceutical R&D Planning with AI-Powered Clinical Intelligence
OZMOSI and Planview have announced a significant partnership aimed at transforming how pharmaceutical organizations approach research and development (R&D) planning.…
Read More
Nucleai and Sirona Dx Forge Strategic Alliance to Revolutionize Spatial Proteomics for Drug Development
The pharmaceutical and biotechnology sectors are poised for a significant leap forward in drug development with the formation of a…
Read More
Regeneron Pharmaceuticals and Telix Pharmaceuticals Forge Strategic Alliance to Advance Precision Oncology Through Radiopharmaceutical Innovation
Regeneron Pharmaceuticals and Telix Pharmaceuticals have announced a significant partnership aimed at accelerating the development and commercialization of novel radiopharmaceutical…
Read More
Bristol Myers Squibb and Oxford BioTherapeutics Forge Alliance to Pioneer Novel T-Cell Engager Therapies for Solid Tumors
Bristol Myers Squibb (BMS) and Oxford BioTherapeutics (OBT) have announced a significant strategic alliance aimed at discovering and developing a…
Read MoreYOU MAY HAVE MISSED
